223
Views
0
CrossRef citations to date
0
Altmetric
Review

Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 59-69 | Received 12 Oct 2023, Accepted 13 Dec 2023, Published online: 21 Dec 2023

References

  • Trubiano JA, Chen C, Cheng AC, et al. Antimicrobial allergy ‘labels’ drive inappropriate antimicrobial prescribing: lessons for stewardship. J Antimicrob Chemother. 2016 Jun;71(6):1715–1722.
  • Blumenthal KG, Peter JG, Trubiano JA, et al. Antibiotic allergy. Lancet. 2019 Jan 12;393(10167):183–198. doi: 10.1016/S0140-6736(18)32218-9
  • Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA. 2017 Jul 4;318(1):82–83. doi: 10.1001/jama.2017.6510
  • Chakravorty A, Binder E, Rawlins M, et al. Antibiotic allergy labels and optimal antimicrobial stewardship. Intern Med J. 2022 Mar;52(3):396–402.
  • MacFadden DR, LaDelfa A, Leen J, et al. Impact of reported beta-lactam allergy on inpatient outcomes: A multicenter prospective cohort study. Clin Infect Dis. 2016 Oct 1;63(7):904–910. doi: 10.1093/cid/ciw462
  • Sousa-Pinto B, Cardoso-Fernandes A, Araújo L, et al. Clinical and economic burden of hospitalizations with registration of penicillin allergy. Ann Allergy Asthma Immunol. 2018 Feb;120(2):190–194.e2.
  • Blumenthal KG, Lu N, Zhang Y, et al. Risk of meticillin resistant staphylococcus aureus and clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ. 2018 Jun 27;361:k2400. doi: 10.1136/bmj.k2400
  • Trubiano J, Phillips E. Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’. Curr Opin Infect Dis. 2013 Dec;26(6):526–537. doi: 10.1097/QCO.0000000000000006
  • Europe. WHOROf. Antimicrobial stewardship interventions: a practical guide. 2021 [cited 2023 Sep 10]. Available from: https://apps.who.int/iris/handle/10665/340709
  • Powell N, Stephens J, Kohl D. et al. The effectiveness of interventions that support penicillin allergy assessment and delabeling of adult and pediatric patients by nonallergy specialists: a systematic review and meta-analysis. Int J Infect Dis. 2023 Apr;129:152–161.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018 Oct 2;169(7):467–73. doi: 10.7326/M18-0850
  • Covidence systematic review software VHI. Melbourne (AU); [cited 2023 Apr 18]. Available from: https://www.covidence.org.
  • Allen HI, Vazquez-Ortiz M, Murphy AW, et al. De-labeling penicillin-allergic children in outpatients using telemedicine: potential to replicate in primary care. J Allergy Clin Immunol Pract. 2020;8(5):1750–2. doi: 10.1016/j.jaip.2019.12.034
  • Alqurashi W, Le Saux N, Vyles D, et al. De-labelling penicillin allergy in the Emergency department. J Allergy Clin Immunol. 2023;151(2 Supplement):AB66. doi: 10.1016/j.jaci.2022.12.208
  • Antoon JW, Grijalva CG, Grisso AG, et al. Feasibility of a centralized, pharmacy-led penicillin allergy delabeling program. Hosp. 2022;12(7):E230–E4. doi: 10.1542/hpeds.2021-006369
  • Arnold A, Sommerfield A, Ramgolam A, et al. The role of skin testing and extended antibiotic courses in assessment of children with penicillin allergy: an Australian experience. J Paediatr Child Health. 2019;55(4):428–432. doi: 10.1111/jpc.14220
  • Bauer ME, MacBrayne C, Stein A, et al. A multidisciplinary quality improvement initiative to facilitate penicillin allergy delabeling among hospitalized pediatric patients. Hosp. 2021;11(5):427–434. doi: 10.1542/hpeds.2020-001636
  • Brayson J, Barrett S, Baqir W, et al. CATALYST: challenging antibiotic allergy status. J Antimicrob Chemother. 2023;78(5):1241–1244. doi: 10.1093/jac/dkad081
  • Chigullapalli S, Cartland S, Bilal S. Parents and primary care perspective on penicillin de-labelling in children. Clin Exp Immunol. 2021;51(1):182.
  • Chow TG, Patel G, Mohammed M, et al. Delabeling penicillin allergy in a pediatric primary care clinic. Ann Allergy Asthma Immunol. 2023;130(5):667–669. doi: 10.1016/j.anai.2023.01.034
  • Copaescu AM, Vogrin S, James F, et al. Efficacy of a Clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized Clinical trial. JAMA Intern Med. 2023;183(9):944. doi: 10.1001/jamainternmed.2023.2986
  • Cunha IM, Marques ML, Gouveia J, et al. Allergy work-up on suspected beta-lactam allergy in children: safety of oral challenge without skin testing in nonimmediate reactions. Allergy: Eur J Allergy Clin Immunol. 2020;75(SUPPL 109):599–600.
  • Day W, DeNora AB, Shields D, et al. Penicillin allergy testing and clearance in the operational setting: a proof of concept. J Allergy Clin Immunol. 2023;151(2 Supplement):AB329. doi: 10.1016/j.jaci.2022.12.762
  • DeNora AB, Shields D, Dore M, et al. Penicillin De-labeling for the non-allergist: a primary care clinic. J Allergy Clin Immunol. 2023;151(2 Supplement):AB44. doi: 10.1016/j.jaci.2022.12.139
  • Devchand M, Kirkpatrick CMJ, Stevenson W, et al. Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention. J Antimicrob Chemother. 2019;74(6):1725–1730. doi: 10.1093/jac/dkz082
  • Du Plessis T, Walls G, Jordan A, et al. Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital. J Antimicrob Chemother. 2019;74(5):1438–1446. doi: 10.1093/jac/dky575
  • Exius R, Gabrielli S, Abrams EM, et al. Establishing amoxicillin allergy in children through direct graded oral challenge (GOC): evaluating risk factors for positive challenges, safety, and risk of cross-reactivity to cephalosporines. J Allergy Clin Immunol Pract. 2021 Nov;9(11):4060–4066.
  • Fanizza FA, Stump H, Carter E, et al. Evaluation of a pharmacist-led penicillin allergy testing service in a community health system. J Am Pharm Assoc (2003). 2023;63(1):169–172. doi: 10.1016/j.japh.2022.08.002
  • Fransson S, Boel JB, Mosbech HF, et al. Safe De-labeling of patients at Low risk of penicillin Allergy in Denmark. Int Arch Allergy Immunol. 2022;183(6):640–650. doi: 10.1159/000521708
  • Franzblau L, Awosemusi Y, Sanders J, et al. Improving Access to penicillin allergy testing among pregnant patients in an obstetrics clinic. J Allergy Clin Immunol. 2023;151(2 Supplement):AB58. doi: 10.1016/j.jaci.2022.12.183
  • Ghassemian A, Sadi G, Mak R, et al. Virtually supported penicillin allergy de-labelling during COVID-19. Allergy Asthma Clin Immunol. 2023;19(1):17. doi: 10.1186/s13223-023-00770-x
  • Ham YY, Joshi S, Sukerman E, et al. Implementation of pharmacist-driven penicillin allergy evaluation and testing with a focus on bypassing penicillin skin testing at an academic medical center. Open Forum Infect. 2020;7(SUPPL 1):S95. doi: 10.1093/ofid/ofaa439.221
  • Hearsey D, Elkhalifa S, Sandoe J, et al. Removal of incorrect penicillin allergy labels in a UK hospital. Clin Microbiol Infect. 2023;29(10):1338.e1–1338.e4. doi: 10.1016/j.cmi.2023.06.024
  • Iammatteo M, Alvarez Arango S, Ferastraoaru D, et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract. 2019;7(1):236–243. doi: 10.1016/j.jaip.2018.05.008
  • Koo G, Stollings JL, Lindsell C, et al. Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. J Allergy Clin Immunol Pract. 2022;10(6):1660–3.e2. doi: 10.1016/j.jaip.2022.01.041
  • Kuruvilla M, Shih J, Patel K, et al. Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy. Allergy Asthma Proc. 2019;40(1):57–61. doi: 10.2500/aap.2019.40.4184
  • Kyi L, Heke E, McPhee S, et al. Direct oral challenge for rapid penicillin de-labelling in acute admitted general medical patients. Intern Med J. 2018;48(Supplement 6):13.
  • Labrosse R, Paradis L, Lacombe-Barrios J, et al. Efficacy and safety of 5-day challenge for the evaluation of nonsevere amoxicillin allergy in children. J Allergy Clin Immunol Pract. 2018;6(5):1673–1680. doi: 10.1016/j.jaip.2018.01.030
  • Lanoue D, MacFadden D, Vanwalraven C, et al. The development and implementation of a proactive penicillin allergy de-labelling program for low risk inpatients at the Ottawa hospital. Allergy Asthma Clin Immunol. 2022;18(SUPPL 1):56.
  • Li J, Cvetanovski V, Fernando S. Single-step direct drug provocation testing is safe for delabelling selected non-low-risk penicillin allergy labels. Ann Allergy Asthma Immunol. 2021;127(2):232–235. doi: 10.1016/j.anai.2021.04.008
  • Li J, Shahabi-Sirjani A, Figtree M, et al. Safety of direct drug provocation testing in adults with penicillin allergy and association with health and economic benefits. Ann Allergy Asthma Immunol. 2019;123(5):468‐75. doi: 10.1016/j.anai.2019.08.005
  • Livirya S, Pithie A, Chua I, et al. Oral amoxicillin challenge for low-risk penicillin allergic patients. Intern Med J. 2022;52(2):295–300. doi: 10.1111/imj.14978
  • Mak R, Yuan Zhang B, Paquette V, et al. Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital. J Allergy Clin Immunol Pract. 2022 Jul;10(7):1919–21.e1.
  • Mir A, Lanoue D, Zanichelli V, et al. Introduction of a penicillin allergy De-labelling program with direct oral challenge is associated with increased downstream utilization of beta-lactam antimicrobials: a multicenter parallel cohort study with crossover evaluation. medRxiv. 2023;A77.
  • Mustafa SS, Conn K, Ramsey A. Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial. J Allergy Clin Immunol Pract. 2019;7(7):2163‐2170. doi: 10.1016/j.jaip.2019.05.037
  • Pachasidchai C, Suksawat Y, Yooma P, et al. Safety of direct oral provocation in children with mild beta-lactam hypersensitivity reactions. Pediatr Allergy Immunol. 2023;34(2):e13927. doi: 10.1111/pai.13927
  • Paul Lim P, Desai AP, Ruda Wessell K, et al. Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct graded oral amoxicillin challenge. Open Forum Infect. 2022;9(Supplement 2):S309. doi: 10.1093/ofid/ofac492.612
  • Pentland J, Vance G, Michaelis L, et al. Outcomes of s-lactam drug allergy challenges: a retrospective audit in a tertiary children’s allergy service. Allergy: Eur J Allergy Clin Immunol. 2017;72(Supplement 103):572.
  • Petersen BT, Gradman J. Diagnosing penicillin allergy in children: results of a 5-days challenge. Clin Transl Allergy. 2018;8(Supplement 2).
  • Piazza MJ, Lichtenberger P, Bjork L, et al. Feasibility of a proactive amoxicillin oral challenge program for inpatients with penicillin allergy at the Miami VAMC. Open Forum Infect. 2021;8(SUPPL 1):S173. doi: 10.1093/ofid/ofab466.320
  • Ramsey A, Mustafa SS. A randomized trial of penicillin skin testing versus 2-step direct challenge for penicillin allergy during pregnancy. J Allergy Clin Immunol. 2023;151(2):AB207. doi: 10.1016/j.jaci.2022.12.646
  • Ramsey A, Mustafa SS, Holly AM, et al. Direct challenges to penicillin-based antibiotics in the inpatient setting. J Allergy Clin Immunol Pract. 2020;8(7):2294–301. doi: 10.1016/j.jaip.2020.02.033
  • Roberts H, Mill C, Ng K, et al. Assessing the validity and reliability of a penicillin allergy de-labeling questionnaire in pediatric patients. Allergy Asthma Clin Immunol. 2017;14(Supplement 1).
  • Saravanabavan S, Aulakh A, Douglas J, et al. Penicillin de-labelling in vancouver, British Columbia, Canada: comparison of approaches, outcomes and future directions. Allergy Asthma Clin Immunol. 2023;19(1):30. doi: 10.1186/s13223-023-00777-4
  • Savic L, Gurr L, Kaura V, et al. Penicillin allergy de-labelling ahead of elective surgery: feasibility and barriers. Br J Anaesth. 2019;123(1):e110–e6. doi: 10.1016/j.bja.2018.09.009
  • Savic L, Kaura V, Gurr L, et al. Penicillin allergy De-labelling in the elective surgical population (PADLES). Clin Exp Immunol. 2018;48(11):1525.
  • Sertori R, Valerio C, Campbell DE, et al. A review of paediatric penicillin allergy at CHW, Sydney. Intern Med J. 2015;45(Supplement 4):4–5.
  • Steenvoorden L, Bjoernestad EO, Kvesetmoen TA, et al. De-labelling penicillin allergy in acutely hospitalized patients: a pilot study. BMC Infect Dis. 2021;21(1):1083. doi: 10.1186/s12879-021-06794-1
  • Stein A, MacBrayne C, Yang C, et al. Clinical pathway to increase rates of penicillin allergy De-labeling. J Allergy Clin Immunol. 2020;145(2 Supplement):AB76. doi: 10.1016/j.jaci.2019.12.664
  • Stevenson B, Trevenen M, Klinken E, et al. Multicenter Australian study to determine criteria for low- and high-risk penicillin testing in outpatients. J Allergy Clin Immunol Pract. 2020;8(2):681–9.e3. doi: 10.1016/j.jaip.2019.09.025
  • Stone C, Lindsell C, Stollings J, et al. Risk-stratified management offers a safe approach to removing low-risk penicillin allergy labels in the Intensive care Unit. J Allergy Clin Immunol. 2020;145(2 Supplement):AB94. doi: 10.1016/j.jaci.2019.12.592
  • Su C, Kuster J, Belmont A, et al. Evaluating a penicillin allergy Clinical decision-making tool to enhance penicillin allergy De-labeling. J Allergy Clin Immunol. 2023;151(2 Supplement):AB61. doi: 10.1016/j.jaci.2022.12.192
  • Trubiano JA, Smibert O, Douglas A, et al. The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study. Open Forum Infect. 2018;5(12). doi: 10.1093/ofid/ofy306
  • Trubiano JA, Vogrin S, Mitri E, et al. The who, What, when, and where of inpatient direct oral penicillin challenge-implications for health services implementation. Clin Infect Dis. 2023;77(1):19–22. doi: 10.1093/cid/ciad156
  • Vyles D, Chiu A, Routes J, et al. Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit. J Allergy Clin Immunol Pract. 2020;8(3):1126‐8.e1. doi: 10.1016/j.jaip.2019.09.022
  • Waldram JD, Tucker MH. Amoxicillin challenges in marine recruits reporting penicillin allergy. J Allergy Clin Immunol. 2016;137(2 SUPPL. 1):AB37. doi: 10.1016/j.jaci.2015.12.123
  • Waldron JL, Hackett J, Chaung YL, et al. Oral penicillin challenge in adult community Practice and primary care, Australia. J Allergy Clin Immunol Pract. 2023;11(12):3786–3788.e3. doi: 10.1016/j.jaip.2023.08.013
  • Vyles D, Adams J, Chiu A, et al. Allergy testing in children with low-risk penicillin allergy symptoms. Pediatrics. 2017 Aug;140(2). doi: 10.1542/peds.2017-0471
  • Devchand M, Urbancic KF, Khumra S, et al. Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool. J Allergy Clin Immunol Pract. 2019 Mar;7(3):1063–5.e5.
  • Trubiano JA, Vogrin S, Chua KYL, et al. Development and validation of a penicillin allergy Clinical decision rule. JAMA Intern Med. 2020;180(5):745–752. doi: 10.1001/jamainternmed.2020.0403
  • Stone CA Jr., Stollings JL, Lindsell CJ, et al. Risk-stratified management to remove low-risk penicillin allergy labels in the ICU. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1572–1575. doi: 10.1164/rccm.202001-0089LE
  • Banks TA, Tucker M, Macy E. Evaluating penicillin allergies without skin testing. Curr Allergy Asthma Rep. 2019 Mar 22;19(5):27. doi: 10.1007/s11882-019-0854-6
  • Bourke J, Pavlos R, James I, et al. Improving the effectiveness of penicillin allergy De-labeling. J Allergy Clin Immunol Pract. 2015 May;3(3):365–34.e1. doi: 10.1016/j.jaip.2014.11.002
  • Kuruvilla M, Thomas J. Direct oral amoxicillin challenge without antecedent penicillin skin testing in low-risk patients. Ann Allergy Asthma Immunol. 2018;121(5):627–628. doi: 10.1016/j.anai.2018.07.024
  • Kaur SA, Parker B, Parker B. Implementation of the PEN-FAST penicillin allergy screening tool in the Emergency department during medication reconciliation. Open Forum Infect Dis. 2021;8(Supplement_1):S137–8. doi: 10.1093/ofid/ofab466.232
  • Copaescu AM, Vogrin S, Shand G, et al. Validation of the PEN-FAST score in a pediatric population. JAMA Netw Open. 2022 Sep 1;5(9):e2233703. doi: 10.1001/jamanetworkopen.2022.33703
  • Wojcik G, Ring N, McCulloch C, et al. Understanding the complexities of antibiotic prescribing behaviour in acute hospitals: a systematic review and meta-ethnography. Arch Public Health. 2021 Jul 23;79(1):134. doi: 10.1186/s13690-021-00624-1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.